In addition, Sun et al. compared the levels of CXCL12 in different tissues and found that, in both human and mouse models, the levels of CXCL12 are higher in the prostate cancer–preferred metastatic tissues than in those rarely targeted [112]. This evidence concerns the gene CXCL12 and prostate cancer.